Adagene Inc. SEC filings ADAG
Adagene Inc. has 191 filings in SEC EDGAR's recent list, going back to Sep 22, 2020. Its latest annual report, Form 20-F, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 25, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jan 9, 2026 | — |
| CORRESP | Letter to the SEC | Jan 7, 2026 | — |
| EFFECT | Filing | May 30, 2025 | — |
| CORRESP | Letter to the SEC | May 28, 2025 | — |
| CORRESP | Letter to the SEC | May 23, 2025 | — |
| UPLOAD | Letter from the SEC | May 21, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 11, 2023 | — |
| CORRESP | Letter to the SEC | Jul 10, 2023 | — |
| CORRESP | Letter to the SEC | Jun 16, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 5, 2023 | — |
| EFFECT | Filing | May 26, 2022 | — |
| CORRESP | Letter to the SEC | May 24, 2022 | — |
| CORRESP | Letter to the SEC | May 13, 2022 | — |
| UPLOAD | Letter from the SEC | May 6, 2022 | — |
| DEL AM | Form del am | May 2, 2022 | — |
| SEC STAFF LETTER | Filing | Feb 8, 2021 | — |
| EFFECT | Filing | Feb 8, 2021 | — |
| EFFECT | Filing | Feb 8, 2021 | — |
| CERT | 8a cert | Feb 8, 2021 | — |
| CORRESP | Letter to the SEC | Feb 4, 2021 | — |
| CORRESP | Letter to the SEC | Feb 4, 2021 | — |
| CORRESP | Letter to the SEC | Feb 4, 2021 | — |
| 8-A12B | Filing | Feb 3, 2021 | — |
| CORRESP | Letter to the SEC | Feb 3, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 1, 2021 | — |
| CORRESP | Letter to the SEC | Feb 1, 2021 | — |
| CORRESP | Letter to the SEC | Feb 1, 2021 | — |
| CORRESP | Letter to the SEC | Feb 1, 2021 | — |
| CORRESP | Letter to the SEC | Feb 1, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 28, 2021 | — |
| CORRESP | Letter to the SEC | Jan 19, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2020 | — |
| DRSLTR | Filing | Nov 24, 2020 | — |
| DRS/A | Filing | Nov 24, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 12, 2020 | — |
| DRSLTR | Filing | Oct 27, 2020 | — |
| DRS/A | Filing | Oct 27, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 20, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 20, 2020 | — |
| DRSLTR | Filing | Sep 22, 2020 | — |
| DRS | Filing | Sep 22, 2020 | — |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ADAG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Jiangsu, China
- SEC filer status
- Accelerated filer, Emerging growth company
- SEC CIK
- 1818838
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.